Analysis of E2 amino acid variants of human papillomavirus types 16 and 18 and their associations with lesion grade and HLA DR/DQ type

International Journal of Cancer

Volumn 73, Issue 5, 1997, Pages 651-655

  Terry, George ^a,b   Ho, Linda ^b   Cuzick, Jack ^a  

^a IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; DNA BINDING PROTEIN; E2 PROTEIN, HUMAN PAPILLOMAVIRUS TYPE 16; HLA ANTIGEN CLASS 2; HLA DQ ANTIGEN; HLA DR ANTIGEN; ONCOGENE PROTEIN E2, HUMAN PAPILLOMAVIRUS TYPE 18; ONCOPROTEIN; PRIMER DNA; VIRUS DNA;

ARTICLE; CHEMISTRY; FEMALE; GENETIC VARIABILITY; GENETICS; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PAPILLOMA VIRUS; PATHOLOGY; POLYMERASE CHAIN REACTION; UTERINE CERVIX; UTERINE CERVIX TUMOR; VIROLOGY; VIRUS INFECTION;

AMINO ACIDS; BASE SEQUENCE; CERVIX UTERI; DNA PRIMERS; DNA, VIRAL; DNA-BINDING PROTEINS; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HLA-DQ ANTIGENS; HLA-DR ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; TUMOR VIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VARIATION (GENETICS);

EID: 0031588344     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971127)73:5<651::AID-IJC7>3.0.CO;2-W     Document Type: Article

References (20)

1. APPLE, R.J., ERLICH, H.A., KLITZ W., MANOS, M.M., BECKER, T.M. and WHEELER, C.M., HLA DR-DQ associations with cervical carcinoma show papillomavirus-type specificity. Nature (Genet.), 6, 157-162 (1994).
2. BOSCH, F.X. and 16 OTHERS, Human papillomavirus and cervical intraepithelial neoplasia grade III/carcinoma m situ: a case-control study in Spain and Colombia. Cancer Epidemiol. Biomarkers Prev., 2, 415-422 (1993).
3. CULLEN, A.P., REID, R., CAMPION, M. and LORINCX, A.T., Analysis of the physical state of different human papillomavirus DNAs intraepithelial and invasive cervical neoplasm. J. Virol., 65, 606-612 (1991).
4. CUZICK, J., SZAREWSKI, A., TERRY, G., HO, L., HANBY, A., MADDOX, P., ANDERSON, M., KOCJAN, G., STEELE, S.J. and GUILLEBAUD, J., HPV testing in primary cervical screening. Lancet, 345, 1533-1536 (1995).
5. DE SANJOSE, S. and 14 OTHERS, Serological response to HPV16 in CIN-III and cervical-cancer patients. Case-control studies in Spain and Colombia. Int. J. Cancer, 66, 70-74 (1996).
6. DILLNER, J., Mapping of linear epitopes of human papillomavirus type 16: the E1, E2, E4, E5, D6 and E7 open reading frames. Int. J. Cancer, 46, 703-711 (1990).
7. DILLNER, L., ZELLBI, A., AVALL-LUNDQVIST, E., HEINO, P., EKLUND, C., PETTERSSON, C.A., FORSLUND, O., HANNSSON, B.G., GRADDIEN, M. and BISTOLETTI, P., Association of serum antibodies against defined epitopes of human papillomavirus L1, E2, and E7 antigens and of HPV DNA in incident cervical cancer. Cancer Detect. Prev., 19, 381-393 (1995).
8. ELLIS, J.R.M., KEATING, P.J., BAIRD, J., HOUNSELL, E.F., RENOUE, D.V., ROWE, M., HOPKINS, D., DUGGAN-KEEN, M.F., BARTHOLOMEW, J.S., YOUNG, L.S. and STERN, P.L., The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer. Nature (Med.), 1, 464-470 (1995).
9. GAUTHIER, J.-M., DILLNER, J. and YANIV, M., Structural analysis of the human papillomavirus type 16-E2 transactivator with antipeptide antibodies reveals a high mobility region linking the transactivation and the DNA-binding domains. Nucleic Acids Res., 19, 7073-7079 (1991).
10. GIRI, I. and YANIV, M., Structural and mutational analysis of E2 transactivating proteins of papillomaviruses reveals three distinct functional domains. EMBO J., 7, 2823-2829 (1988).
11. HAMSIKOVA, E., NOVAK, J., HOFMANNOVA, V. MUÑOZ, N., BOSCH, F.X., DE SANJOSE, S., SHAH, K.V., ROTH, Z. and VONKA, V., Presence of antibodies to seven human-papillomavirus-type-16-derived peptides in cervical cancer patients and healthy controls. J. infect. Dis., 170, 1424-1431 (1994).
12. HECHT, J.L., KADISH, A.S., JIANG, G. and BURK, R.D., Genetic characterization of the human papillomavirus (HPV) 18 E2 in clinical specimens suggests the presence of a subtype with decreased oncogenic potential. Int. J. Cancer, 60, 369-376 (1995).
13. LENNER, P., DILLNER, J., WIKLUND, F. HALLMANS, G. and STENDAHL, U., Serum antibody responses against human papillomavirus in relation to tumor characteristics, response to treatment, and survival in carcinoma of the uterine cervix. Cancer Immunol. Immunother., 40, 201-205 (1995).
14. LONDESBOROUGH, P., HO, L., TERRY, G., CUZICK, J., WHEELER, C. and SINGER, A., Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities. Int. J. Cancer, 69, 364-368 (1996).
15. MATSUKURA, T., KOI, S. and SUGASE, M., Both episomal and integrated forms of human papillomavirus type 16 are involved in invasive cervical cancers. Virology, 172, 63-72 (1989).
16. ODUNSI, K., TERRY, G., HO, L., BELL, J., CUZICK, J. and GANESAN, T.S., Susceptibility to human papillomavirus-associated cervical intra-epithelial neoplasia is determined by specific HLA DR-DQ alleles. Int. J. Cancer, 67, 595-602 (1996).
17. PICCINI, A., STOREY, A., MASSIMI, P. and BANKS, L., Mutations in the human papillomavirus type 16 E2 protein identify multiple regions of the protein involved in binding to E1. J. gen. Virol., 76, 2909-2913 (1995).
18. STRICKLER, H.D., DILLNER, J., SCHIFFMAN, M.H., EKLUND, C., GLASS, A.G., GREER, C., SCOTT, D.R., SHERMAN, M.E., KURMAN, R.J. and MANOS, M., A seroepidemologic study of HPV infection and incident cervical squamous intraepithelial lesions. Viral Immunol., 7, 169-177 (1994).
19. YAMADA, T., MANOS, M.M., PETO, J., GREER, C.E., MUÑOZ, N., BOSCH, F.X. and WHEELER, C.M., Human papillomavirus type 16 sequence variation in cervical cancers: a world-wide perspective. J. Virol., 71, 2463-2472 (1997).
20. YAMADA, T., WHEELER, C.M., HALPERN, A.L., STEWART, A.-C.M., HILDESHEIM, A. and JENISON, S.A., Human papillomavirus type 16 variant lineages in United States populations characterised by nucleotide sequence analysis of the E6, L2 and L1 coding segments. J. Virol., 69, 7743-7753 (1995).